Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Polycythemia Vera 2 Thrombosis 1 Thrombocytosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycythemia 1 Myeloproliferative Disorders 1 Lymphoma, Non-Hodgkin 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Acute 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia 1 Hodgkin Disease 1 Glioma 1 Glioblastoma 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Epstein-Barr Virus Infections 1 Bites and Stings 1 Adenocarcinoma Of Esophagus 1

Interventions

pembrolizumab 2 Immune Checkpoint Inhibitors 2 Cytochrome P-450 Enzyme System 2 enzalutamide 1 blinatumomab 1 abiraterone 1 Hydroxyurea 1 Etanercept 1 Androgen Receptor Antagonists 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Bites and Stings × Hydroxyurea × Clear all

NCT06063317 2026-03-06

OASIS

Imugene Limited

Phase 1 Terminated

Bites and Stings

Data powered by HemOnc (CC BY 4.0) Colophon ⚡